Skip to main content
. Author manuscript; available in PMC: 2010 Apr 16.
Published in final edited form as: Eur Arch Psychiatry Clin Neurosci. 1999;249(Suppl 4):69–82. doi: 10.1007/pl00014188

Table 1.

A multilevel view of disturbed associations in schizophrenia: Is there a common theme of failure of suppression/inhibition?

Clinical level:
 Presence of thought disorder.
 Bleuler: “associations which normal individuals will regard as incorrect, bizarre, and utterly unpredictable”.
Inference:
 Loose associations are one of the fundamental disturbances of schizophrenia.
Behavioral experimental level:
 Abnormal connectivity in connectionist network model.
 High connectivity dominates, context less important.
Inference:
 Failure of suppression of dominant associations = ? failure of context utilization.
Functional neural systems level:
 N400 studies of language and word pairs.
 Reduced N400 amplitude for word pairs when second word is related to first (short inter-word intervals).
 Increased N400 to congruent sentence endings.
Inferences:
 Faulty search of lexicon, as indexed by N400.
 More dominant associations prevail. Failure to use context. Failure to suppress dominant associations.
Anatomical systems level:
MRI studies:
 Reduced MRI gray matter volume in language processing areas of the brain (including superior temporal gyrus/Wernicke’s area).
 Volume reduction correlated with the degree of thought disorder.
Inference:
 Abnormal anatomical substrate for language in schizophrenia.
Cellular and molecular level:
 In vitro model: Exogenous NMDA receptor blockers (Psychotomimetics) –
 Suppress recurrent inhibition more than feed-forward excitation.
 Disturbance in a ‘realistic’ neuronal model leads to failure to suppress previously learned Hebbian associative patterns.
 Post-mortem data: Endogenous NMDA receptor blockers (NAAG) and/or other abnormalities affecting inhibitory neurons may be present in schizophrenia.
Inferences:
 Failure of inhibition at the cellular level.
 Possible excitotoxic effects of resultant abnormal excitation, and progression of neural tissue damage. Developmental anomalies secondary to NMDA abnormalities.
HHS Vulnerability Disclosure